Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

TCTMD’s Top 10 Most Popular Stories for July 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2025

July 31, 2025

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

July 24, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

May 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

May 20, 2025

April 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

April 18, 2025

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

News Daily News

No Spike in Cardiac Arrests, Deaths in Young Athletes During COVID-19

February 26, 2025

February 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

February 01, 2025

January 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

January 24, 2025

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

News Daily News

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

January 23, 2025

TCTMD’s Biggest News of 2024: Stories, Videos, and More

News Opinion Editor's Corner

TCTMD’s Biggest News of 2024: Stories, Videos, and More

January 01, 2025

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

November 12, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.